Close

Protalix BioTherapeutics (PLX) Enters Notes Exchange Agreement, Conv. Notes Private Placement

December 1, 2016 5:02 PM EST Send to a Friend
Protalix BioTherapeutics, Inc. (NYSE: PLX) announced the entry into a definitive exchange agreement relating to an exchange (the “Exchange”) of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login